{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:42:18Z","timestamp":1790934138058,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051563","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T22:09:28Z","timestamp":1355350168000},"page":"e51563","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition"],"prefix":"10.1371","volume":"7","author":[{"given":"Francesca","family":"Cavallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Antinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Houldsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Bosl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju S. K.","family":"Chaganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Moynahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Barchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc1120","article-title":"Curing metastatic cancer: lessons from testicular germ-cell tumours","volume":"3","author":"JR Masters","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12015-007-0002-x","article-title":"The stem cell identity of testicular cancer","volume":"3","author":"AT Clark","year":"2007","journal-title":"Stem Cell Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Testicular germ-cell cancer","volume":"337","author":"GJ Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.299.6.672","article-title":"Medical treatment of advanced testicular cancer","volume":"299","author":"DR Feldman","year":"2008","journal-title":"JAMA"},{"key":"ref5","first-page":"362","article-title":"Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer","volume":"54","author":"JW Moul","year":"1994","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1002::AID-CNCR27>3.0.CO;2-A","article-title":"Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis","volume":"83","author":"A Heidenreich","year":"1998","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.1990.8.1.16","article-title":"Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial","volume":"8","author":"J Pont","year":"1990","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e19198","DOI":"10.1371\/journal.pone.0019198","article-title":"p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to Cisplatin","volume":"6","author":"M Gutekunst","year":"2011","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.20134","article-title":"Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines","volume":"110","author":"C Welsh","year":"2004","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1476-4598-9-248","article-title":"Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression","volume":"9","author":"S Usanova","year":"2010","journal-title":"Mol Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/cr.2008.1","article-title":"Homologous recombination in DNA repair and DNA damage tolerance","volume":"18","author":"X Li","year":"2008","journal-title":"Cell Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1073\/pnas.0407796102","article-title":"Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair","volume":"102","author":"K Nakanishi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1128\/MCB.00086-09","article-title":"XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair","volume":"29","author":"N Bhagwat","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nsmb.2029","article-title":"Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication","volume":"18","author":"K Nakanishi","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2008.08.030","article-title":"Mechanism of replication-coupled DNA interstrand crosslink repair","volume":"134","author":"M Raschle","year":"2008","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1128\/MCB.20.21.8283-8289.2000","article-title":"DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links","volume":"20","author":"YM Akkari","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1093\/nar\/gkp705","article-title":"The ERCC1\/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links","volume":"37","author":"AZ Al-Minawi","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"N McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2008.16.0812","article-title":"A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair","volume":"26","author":"A Ashworth","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1073\/pnas.1013715108","article-title":"Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells","volume":"108","author":"AG Patel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1432-0436.1989.tb00602.x","article-title":"Isolation and characterization of a multipotent clone of human embryonal carcinoma cells","volume":"42","author":"MF Pera","year":"1989","journal-title":"Differentiation"},{"key":"ref22","first-page":"220","article-title":"Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT","volume":"68","author":"I Damjanov","year":"1993","journal-title":"Lab Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1073\/pnas.2235735100","article-title":"Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors","volume":"100","author":"JM Sperger","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","first-page":"243","article-title":"Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7)","volume":"71","author":"PW Andrews","year":"1994","journal-title":"Lab Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1634\/stemcells.2006-0236","article-title":"Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research","volume":"25","author":"R Josephson","year":"2007","journal-title":"Stem Cells"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2005.07.016","article-title":"Does gammaH2AX foci formation depend on the presence of DNA double strand breaks?","volume":"229","author":"A Takahashi","year":"2005","journal-title":"Cancer Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2125.2004.02082.x","article-title":"Population pharmacokinetics of total and unbound plasma cisplatin in adult patients","volume":"57","author":"S Urien","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0959-8049(96)00033-0","article-title":"Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways","volume":"32A","author":"JR Masters","year":"1996","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1086\/512486","article-title":"First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure","volume":"80","author":"NG Jaspers","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/7.6.969","article-title":"Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms","volume":"7","author":"Y Matsumura","year":"1998","journal-title":"Hum Mol Genet"},{"key":"ref31","first-page":"59","article-title":"Establishment by SV40 transformation and characteristics of a cell line of xeroderma pigmentosum belonging to complementation group F. Mutat Res","volume":"112","author":"T Yagi","year":"1983"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1128\/MCB.24.21.9305-9316.2004","article-title":"Genetic steps of mammalian homologous repair with distinct mutagenic consequences","volume":"24","author":"JM Stark","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrm2851","article-title":"Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis","volume":"11","author":"ME Moynahan","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","article-title":"XRCC3 promotes homology-directed repair of DNA damage in mammalian cells","volume":"13","author":"AJ Pierce","year":"1999","journal-title":"Genes Dev"},{"key":"ref35","first-page":"373","article-title":"Measuring recombination proficiency in mouse embryonic stem cells","volume":"291","author":"AJ Pierce","year":"2005","journal-title":"Methods Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1158\/0008-5472.CAN-09-4295","article-title":"PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors","volume":"70","author":"B McEllin","year":"2010","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/sj.onc.1208368","article-title":"Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors","volume":"24","author":"D Di Vizio","year":"2005","journal-title":"Oncogene"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-11-2189","article-title":"PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy","volume":"18","author":"M Fraser","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1097-2765(00)80202-6","article-title":"BRCA1 controls homology-directed DNA repair","volume":"4","author":"ME Moynahan","year":"1999","journal-title":"Mol Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molcel.2012.02.015","article-title":"BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair","volume":"46","author":"SF Bunting","year":"2012","journal-title":"Mol Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"H Farmer","year":"2005","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"PC Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"17079","DOI":"10.1073\/pnas.0806092105","article-title":"High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs","volume":"105","author":"S Rottenberg","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"A Tutt","year":"2010","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1073\/pnas.0904783107","article-title":"Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130","volume":"107","author":"DC Hegan","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr2445","article-title":"A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors","volume":"11","author":"D Inbar-Rozensal","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref47","first-page":"3547","article-title":"BRCA2 is required for ionizing radiation-induced assembly of RAD51 complex in vivo","volume":"59","author":"SS Yuan","year":"1999","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1158\/0008-5472.CAN-09-4716","article-title":"Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells","volume":"70","author":"P Gottipati","year":"2010","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ijc.25683","article-title":"How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation","volume":"128","author":"A Mangerich","year":"2011","journal-title":"Int J Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1158\/1535-7163.MCT-09-1027","article-title":"Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair","volume":"9","author":"DA Loser","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2002.20.6.1551","article-title":"Role of P53 and MDM2 in treatment response of human germ cell tumors","volume":"20","author":"AM Kersemaekers","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bcp.2009.09.020","article-title":"DNA damage response to the Mdm2 inhibitor nutlin-3","volume":"79","author":"R Verma","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"PM Voorhoeve","year":"2006","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/cddis.2011.33","article-title":"Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas\/FasL pathway","volume":"2","author":"R Koster","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6605166","article-title":"Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines","volume":"101","author":"T Zaremba","year":"2009","journal-title":"Br J Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1158\/0008-5472.CAN-09-1237","article-title":"Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue","volume":"69","author":"NR Bhagwat","year":"2009","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.ejca.2007.07.010","article-title":"Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis","volume":"43","author":"L Tentori","year":"2007","journal-title":"Eur J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:00:51Z","timestamp":1589032851000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051563"}},"subtitle":[],"editor":[{"given":"Michael","family":"Lichten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051563","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}